Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL331372 (CGS-21680) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
A1 receptor/Adenosine A1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL226] [GtoPdb: 18] [UniProtKB: P30542] | ||||||||
ChEMBL | Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cell membranes incubated for 120 mins by scintillation counting method | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2015) 58: 3253-3267 [PMID:25780876] |
GtoPdb | - | - | 6.4 | pKi | - | - | - |
Biochem Pharmacol (2004) 68: 1985-93 [PMID:15476669]; Nat Rev Drug Discov (2006) 5: 247-64 [PMID:16518376] |
ChEMBL | Displacement of [3H]R-PIA from human adenosine A1 receptor expressed in CHO cells | B | 6.42 | pKi | 380 | nM | Ki | ACS Med Chem Lett (2014) 5: 1043-1048 [PMID:25221664] |
ChEMBL | Displacement of [3H]N6-phenylisopropyladenosine from human A1 adenosine receptor expressed in CHO cell membranes after 60 mins | B | 6.42 | pKi | 380 | nM | Ki | J Med Chem (2012) 55: 538-552 [PMID:22104008] |
ChEMBL | Inhibition of [3H]DPCPX binding to human adenosine A1 receptor expressed in CHO cells | B | 6.52 | pKi | 302 | nM | Ki | J Med Chem (2004) 47: 4041-4053 [PMID:15267242] |
ChEMBL | Agonist activity at human adenosine receptor A1 | B | 6.54 | pKi | 290 | nM | Ki | Eur J Med Chem (2019) 179: 310-324 [PMID:31255928] |
ChEMBL | Binding affinity to human recombinant adenosine A1 receptor | B | 6.54 | pKi | 290 | nM | Ki | J Med Chem (2014) 57: 3623-3650 [PMID:24164628] |
ChEMBL | Displacement of [3H]CCPA from human recombinant adenosine A1 receptor | B | 6.54 | pKi | 289 | nM | Ki | Bioorg Med Chem (2013) 21: 436-447 [PMID:23245803] |
ChEMBL | Displacement of [3H]CCPA from human recombinant adenosine A1 receptor | B | 6.54 | pKi | 289 | nM | Ki | ACS Med Chem Lett (2011) 2: 890-895 [PMID:24900277] |
ChEMBL | Binding affinity for human adenosine A1 receptor | B | 6.54 | pKi | 289 | nM | Ki | J Med Chem (1999) 42: 1384-1392 [PMID:10212124] |
ChEMBL | Agonist activity at human adenosine A1 receptor expressed in CHO cells by GTPPgammaS binding assay | B | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2010) 20: 1219-1224 [PMID:20031406] |
ChEMBL | Binding against human adenosine A1 receptor | B | 5.19 | pEC50 | 6437 | nM | EC50 | Bioorg Med Chem Lett (1998) 8: 691-694 [PMID:9871584] |
ChEMBL | Agonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay | F | 6.3 | pEC50 | 501.19 | nM | EC50 | Medchemcomm (2014) 5: 192-196 |
A1 receptor/Adenosine A1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL318] [GtoPdb: 18] [UniProtKB: P25099] | ||||||||
ChEMBL | Displacement of [3H]R-PIA from adenosine A1 receptor of Wistar rat forebrain | B | 5 | pKi | 9900 | nM | Ki | J Med Chem (1999) 42: 3463-3477 [PMID:10479279] |
ChEMBL | Binding affinity against adenosine A1 receptor using [3H]-CHA or [3H]PIA as radioligand | B | 5.59 | pKi | 2600 | nM | Ki | J Med Chem (1992) 35: 407-422 [PMID:1738138] |
ChEMBL | Displacement of [3H]CHA from Adenosine A1 receptor in rat cortical membrane | B | 5.59 | pKi | 2600 | nM | Ki | J Med Chem (2002) 45: 420-429 [PMID:11784146] |
ChEMBL | Inhibition of [3H]PIA binding to rat cortical adenosine A1 receptor | B | 5.59 | pKi | 2600 | nM | Ki | J Med Chem (1992) 35: 4143-4149 [PMID:1433217] |
ChEMBL | Displacement of [3H]- DPCPX from adenosine A1 receptor on rat cortical membrane | B | 5.59 | pKi | 2600 | nM | Ki | J Med Chem (1999) 42: 1384-1392 [PMID:10212124] |
ChEMBL | Tested for the binding affinity of A1 receptor by displacing the [3H]-PIA in rat brain membranes | B | 5.59 | pKi | 2600 | nM | Ki | J Med Chem (1994) 37: 3614-3621 [PMID:7932588] |
GtoPdb | - | - | 5.74 | pKi | 1800 | nM | Ki | . A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics (2010) |
ChEMBL | Displacement of [3H]CCPA from adenosine A1 receptor in rat brain cortical membrane after 90 mins by liquid scintillation counting analysis | B | 5.74 | pKi | 1800 | nM | Ki | Bioorg Med Chem (2013) 21: 436-447 [PMID:23245803] |
ChEMBL | Binding affinity towards adenosine A1 receptor in rat brain cortex | B | 5.74 | pKi | 1800 | nM | Ki | J Med Chem (2001) 44: 531-539 [PMID:11170643] |
ChEMBL | Displacement of [3H]CCPA from adenosine A1 receptor in rat brain cortex | B | 5.74 | pKi | 1800 | nM | Ki | ACS Med Chem Lett (2011) 2: 890-895 [PMID:24900277] |
ChEMBL | Adenosine A1 receptor binding was measured in adenosine deaminase (ADA) pretreated rat cortical membranes using [3H]cyclohexyladenosine in the presence of 2-chloroadenosine | B | 5.85 | pKi | 1408 | nM | Ki | J Med Chem (1990) 33: 1919-1924 [PMID:2362269] |
ChEMBL | Binding affinity against adenosine A1 receptor in rat brain membranes using [3H]CHA as radioligand | B | 5.91 | pKi | 1232 | nM | Ki | J Med Chem (1992) 35: 241-252 [PMID:1732541] |
ChEMBL | Inhibition of [3H]CHA binding to adenosine A1 receptor from rat brain membranes | B | 5.91 | pKi | 1232 | nM | Ki | J Med Chem (1992) 35: 2253-2260 [PMID:1613750] |
ChEMBL | Binding affinity against adenosine A1 receptor from rat brain membranes using [3H]cyclohexyladenosine as radioligand. | B | 5.94 | pKi | 1138 | nM | Ki | J Med Chem (1992) 35: 2881-2890 [PMID:1495019] |
ChEMBL | Binding affinity against adenosine A1 receptor from rat brain using [3H]CHA as a radioligand. | B | 6.24 | pKi | 569 | nM | Ki | J Med Chem (1995) 38: 1462-1472 [PMID:7739005] |
ChEMBL | Displacement of [3H]CHA from Adenosine A1 receptor of rat brain | B | 6.24 | pKi | 569 | nM | Ki | J Med Chem (1995) 38: 3581-3585 [PMID:7658444] |
ChEMBL | Functional activity against adenosine A1 receptor from rat atria. | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (1995) 38: 1462-1472 [PMID:7739005] |
ChEMBL | Activity at Adenosine A1 receptor of rat atria | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (1995) 38: 3581-3585 [PMID:7658444] |
ChEMBL | [S]GTP gamma-S binding against adenosine A1 receptor in rat brain | B | 7 | pEC50 | >100 | nM | EC50 | Bioorg Med Chem Lett (1998) 8: 691-694 [PMID:9871584] |
Adenosine A1 receptor in Guinea pig (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2304404] [UniProtKB: P47745] | ||||||||
ChEMBL | Prolongation of the stimulus-QRS interval by 50% of the maximum response at the Adenosine A1 receptor in langendorff guinea pig heart preparation | F | 4.61 | pEC50 | 24547.09 | nM | EC50 | J Med Chem (1991) 34: 1334-1339 [PMID:2016707] |
A2A receptor/Adenosine A2a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL251] [GtoPdb: 19] [UniProtKB: P29274] | ||||||||
ChEMBL | Saturation binding of wild type human Adenosine A2A receptor at pH 8.4 | B | 6.2 | pKd | 632 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Saturation binding of human Adenosine A2A receptor H250N at pH 8.4 | B | 7 | pKd | 99 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Saturation binding characteristics of wild type human Adenosine A2A receptor at pH 7.5 | B | 7.13 | pKd | 74 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Saturation binding of wild type human Adenosine A2A receptor at pH 6.8 | B | 7.44 | pKd | 36.4 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Kd in saturation experiments using [3H]CGS-21680 at WT receptor in COS-7 cells | B | 7.44 | pKd | 36.4 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Kd in saturation experiments using [3H]CGS-21680 at V84L mutant receptor in COS-7 cells | B | 7.56 | pKd | 27.3 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Saturation binding characteristics of wild type human Adenosine A2A receptor at pH 5.5 | B | 7.66 | pKd | 22 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Saturation binding of human Adenosine A2A receptor H250N at pH 7.5 | B | 7.94 | pKd | 11.6 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Saturation binding of human Adenosine A2A receptor (H250N) at pH 6.8 | B | 8.12 | pKd | 7.6 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Kd in saturation experiments using [3H]CGS-21680 at H250N mutant receptor in COS-7 cells | B | 8.12 | pKd | 7.6 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Displacement of [3H]4-[2-[7-amino-2-(2-furyl)-1,2,4-triazolo[1,5-a][1,3,5]triazin-5-yl-amino]ethylphenol from wild type human adenosine A2a receptor expressed in HEK293 cells assessed as radioligand Kd compound preincubated for 30 mins | B | 8.36 | pKd | 4.36 | nM | Kd | ACS Med Chem Lett (2014) 5: 1043-1048 [PMID:25221664] |
ChEMBL | Saturation binding of mutant human Adenosine A2A receptor (H250N) at pH 5.5 | B | 8.37 | pKd | 4.3 | nM | Kd | J Med Chem (1997) 40: 2588-2595 [PMID:9258366] |
ChEMBL | Displacement of [3H]-ZM24135 from human adenosine A2A receptor expressed in HEK293 cells after 1 hr by scintillation counting | B | 6.3 | pKi | 503 | nM | Ki | Eur J Med Chem (2015) 106: 15-25 [PMID:26513641] |
ChEMBL | Displacement of [3H]2-[p-(2-carboxyethyl)phenyl-ethylamino]-5'-N-ethylcarboxamidoadenosine from human adenosine A2a receptor expressed in HEK293 cells | B | 7.15 | pKi | 70 | nM | Ki | ACS Med Chem Lett (2014) 5: 1043-1048 [PMID:25221664] |
ChEMBL | Displacement of [3H]2-[p-(2-carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamido-adenosine from human A2A adenosine receptor expressed in HEK293 cell membranes after 60 mins | B | 7.15 | pKi | 70 | nM | Ki | J Med Chem (2012) 55: 538-552 [PMID:22104008] |
ChEMBL | Inhibition of [3H]ZM-241385 binding to human adenosine A2A receptor expressed in HeLa cells | B | 7.3 | pKi | 50 | nM | Ki | J Med Chem (2004) 47: 4041-4053 [PMID:15267242] |
ChEMBL | Displacement of [3H]CGS21680 from human recombinant adenosine A2A receptor expressed in HEK293T cells by scintillation counting | B | 7.34 | pKi | 46.2 | nM | Ki | Bioorg Med Chem (2009) 17: 4280-4284 [PMID:19481943] |
ChEMBL | Displacement of [3H]CGS21680 from human recombinant adenosine A2A receptor expressed in HEK293T cells | B | 7.34 | pKi | 46.2 | nM | Ki | Bioorg Med Chem (2008) 16: 3825-3830 [PMID:18262425] |
ChEMBL | Displacement of [3H]CGS21680 from human recombinant adenosine A2A receptor expressed in HEK293T cells | B | 7.34 | pKi | 46.2 | nM | Ki | Bioorg Med Chem (2007) 15: 3235-3240 [PMID:17350268] |
ChEMBL | Binding affinity for human adenosine A2A receptor | B | 7.57 | pKi | 27.1 | nM | Ki | J Med Chem (1999) 42: 1384-1392 [PMID:10212124] |
ChEMBL | Agonist activity at human adenosine receptor A2A | B | 7.57 | pKi | 27 | nM | Ki | Eur J Med Chem (2019) 179: 310-324 [PMID:31255928] |
ChEMBL | Displacement of [3H]CGS21680 from human recombinant adenosine A2A receptor | B | 7.57 | pKi | 27 | nM | Ki | ACS Med Chem Lett (2011) 2: 890-895 [PMID:24900277] |
ChEMBL | Displacement of [3H]CGS21680 from human recombinant adenosine A2A receptor expressed in HEK cells | B | 7.57 | pKi | 27 | nM | Ki | Bioorg Med Chem (2013) 21: 436-447 [PMID:23245803] |
ChEMBL | Binding affinity to human recombinant adenosine receptor A2a | B | 7.57 | pKi | 27 | nM | Ki | J Med Chem (2014) 57: 3623-3650 [PMID:24164628] |
ChEMBL | Displacement of [3H]CGS21680 from human recombinant adenosine 2A receptor after 60 mins by gamma counting analysis | B | 7.57 | pKi | 27 | nM | Ki | J Med Chem (2016) 59: 788-809 [PMID:26356532] |
ChEMBL | Displacement of [3H]NECA from human recombinant adenosine A2A receptor expressed in Sf21 cells co-expressing GalphaS2, beta4, gamma2 | B | 7.68 | pKi | 21 | nM | Ki | Bioorg Med Chem Lett (2010) 20: 1219-1224 [PMID:20031406] |
ChEMBL | Displacement of [3H]CGS21680 from human adenosine A2A receptor expressed in CHO cell membranes incubated for 120 mins by scintillation counting method | B | 7.9 | pKi | 12.48 | nM | Ki | J Med Chem (2015) 58: 3253-3267 [PMID:25780876] |
GtoPdb | - | - | 8.1 | pKi | 7.94 | nM | Ki |
Biochem Pharmacol (2004) 68: 1985-93 [PMID:15476669]; J Pharmacol Exp Ther (2005) 315: 329-36 [PMID:16020631]; Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 1-9 [PMID:9459566]; J Med Chem (2004) 47: 4041-53 [PMID:15267242]; J Biol Chem (1995) 270: 13987-97 [PMID:7775460]; Biochem Pharmacol (1999) 57: 65-75 [PMID:9920286]; Br J Pharmacol (1997) 121: 353-60 [PMID:9179373]; Nat Rev Drug Discov (2006) 5: 247-64 [PMID:16518376] |
ChEMBL | Agonist activity at adenosine A2A receptor in human neutrophils assessed as inhibition of fMLP-induced reactive oxygen species release by chemiluminescence assay | F | 7.72 | pIC50 | 19 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 1219-1224 [PMID:20031406] |
ChEMBL | Agonist activity at human Adenosine A2A receptor expressed in yeast cells coexpressed with chimeric GPA1/Galphas after 16 hrs by beta-galactosidase reporter gene assay | B | 4.7 | pEC50 | 19952.62 | nM | EC50 | J Med Chem (2016) 59: 947-964 [PMID:26756468] |
ChEMBL | Agonist activity at human adenosine A2A receptor expressed in CHO cells assessed as stimulation of [3H]cAMP levels by scintillation counting method | F | 7.73 | pEC50 | 18.47 | nM | EC50 | J Med Chem (2015) 58: 3253-3267 [PMID:25780876] |
ChEMBL | Agonist activity at human adenosine A2A receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay | F | 7.9 | pEC50 | 12.59 | nM | EC50 | Medchemcomm (2014) 5: 192-196 |
ChEMBL | Agonist activity at human adenosine A2a receptor expressed in CHO cells assessed as stimulation of cAMP formation after 24 hrs | F | 8.67 | pEC50 | 2.12 | nM | EC50 | ACS Med Chem Lett (2014) 5: 1043-1048 [PMID:25221664] |
ChEMBL | Partial agonist activity at human A2A receptor expressed in HEK293 cell membranes assessed as intrinsic activity by measuring cell index change within 60 mins by Label-Free Impedance-Based Assay | F | 8.85 | pEC50 | 1.41 | nM | EC50 | J Med Chem (2021) 64: 3827-3842 [PMID:33764785] |
A2A receptor/Adenosine A2a receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL302] [GtoPdb: 19] [UniProtKB: P30543] | ||||||||
ChEMBL | Displacement of [3H]CGS21680 from A2A adenosine receptor expressed in rat striatal membranes after 30 mins by liquid scintillation counting | B | 7.57 | pKi | 27 | nM | Ki | J Med Chem (2012) 55: 538-552 [PMID:22104008] |
GtoPdb | - | - | 7.72 | pKi | 19 | nM | Ki | . A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics (2010) |
ChEMBL | Binding affinity towards adenosine A2A receptor in rat brain striatum | B | 7.72 | pKi | 19 | nM | Ki | J Med Chem (2001) 44: 531-539 [PMID:11170643] |
ChEMBL | Binding affinity to rat recombinant adenosine receptor A2a | B | 7.72 | pKi | 19 | nM | Ki | J Med Chem (2014) 57: 3623-3650 [PMID:24164628] |
ChEMBL | Displacement of [3H]CGS21680 from adenosine A2A receptor in rat brain striatum | B | 7.74 | pKi | 18 | nM | Ki | ACS Med Chem Lett (2011) 2: 890-895 [PMID:24900277] |
ChEMBL | Displacement of [3H]CGS21680 from adenosine A2A receptor in rat brain striatal membrane after 60 mins by liquid scintillation counting analysis | B | 7.74 | pKi | 18 | nM | Ki | Bioorg Med Chem (2013) 21: 436-447 [PMID:23245803] |
ChEMBL | Tested for the binding affinity of A2a receptor by displacing the [3H]-CGS- 21680 in rat striatal membranes | B | 7.82 | pKi | 15 | nM | Ki | J Med Chem (1994) 37: 3614-3621 [PMID:7932588] |
ChEMBL | Ability to displace radioligand [3H]- CGS 21680 from adenosine A2A receptor on rat striatal membrane | B | 7.82 | pKi | 15 | nM | Ki | J Med Chem (1999) 42: 1384-1392 [PMID:10212124] |
ChEMBL | Displacement of [3H]NECA from Adenosine A2A receptor in rat striatal membrane | B | 7.82 | pKi | 15 | nM | Ki | J Med Chem (2002) 45: 420-429 [PMID:11784146] |
ChEMBL | Displacement of [3H]-CGS- 21680 from adenosine A2A receptor of rat striatal tissue | B | 7.96 | pKi | 11 | nM | Ki | J Med Chem (1999) 42: 3463-3477 [PMID:10479279] |
ChEMBL | Displacement of [3H]-CGS- 21680 from Adenosine A2A receptor of rat striatum | B | 7.96 | pKi | 11 | nM | Ki | J Med Chem (1995) 38: 3581-3585 [PMID:7658444] |
ChEMBL | Binding affinity against adenosine A2a receptor from rat striatum using [3H]-CGS- 21680 as a radioligand. | B | 7.96 | pKi | 11 | nM | Ki | J Med Chem (1995) 38: 1462-1472 [PMID:7739005] |
ChEMBL | Functional activity against adenosine A2a receptor from rat aorta. | F | 6.94 | pEC50 | 115 | nM | EC50 | J Med Chem (1995) 38: 1462-1472 [PMID:7739005] |
ChEMBL | Functional activity at Adenosine A2A receptor as vasorelaxation of rat aorta | F | 6.94 | pEC50 | 115 | nM | EC50 | J Med Chem (1995) 38: 3581-3585 [PMID:7658444] |
A2B receptor/Adenosine A2b receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL255] [GtoPdb: 20] [UniProtKB: P29275] | ||||||||
GtoPdb | - | - | 5 | pKi | - | - | - |
Mol Pharmacol (1999) 56: 705-13 [PMID:10496952]; Mol Pharmacol (2000) 58: 1349-56 [PMID:11093773]; Nat Rev Drug Discov (2006) 5: 247-64 [PMID:16518376] |
ChEMBL | Inhibition of [3H]DPCPX binding to human adenosine A2B receptor expressed in HEK293 cells | B | 5 | pKi | >10000 | nM | Ki | J Med Chem (2004) 47: 4041-4053 [PMID:15267242] |
ChEMBL | Displacement of [3H]PSB-603 from human recombinant adenosine A2B receptor expressed in CHO cells after 75 mins by liquid scintillation assay | B | 5 | pKi | >10000 | nM | Ki | ACS Med Chem Lett (2011) 2: 890-895 [PMID:24900277] |
ChEMBL | Agonist activity at human adenosine A2B receptor expressed in CHO cells assessed as effect on cAMP production by luciferase reporter gene assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2010) 20: 1219-1224 [PMID:20031406] |
ChEMBL | Agonist activity at human adenosine A2B receptor expressed in CHO cells assessed as stimulation of [3H]cAMP levels by scintillation counting method | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2015) 58: 3253-3267 [PMID:25780876] |
ChEMBL | Agonist activity at human adenosine A2B receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay | F | 7.4 | pEC50 | 39.81 | nM | EC50 | Medchemcomm (2014) 5: 192-196 |
A2B receptor in Rat [GtoPdb: 20] [UniProtKB: P29276] | ||||||||
GtoPdb | - | - | 5 | pKi | >10000 | nM | Ki | . A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics (2010) |
A3 receptor/Adenosine A3 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL256] [GtoPdb: 21] [UniProtKB: P0DMS8] | ||||||||
ChEMBL | Displacement of [125I]APNEA from human Adenosine A3 receptor expressed in HEK 293 cells | B | 6.23 | pKi | 584 | nM | Ki | J Med Chem (2002) 45: 420-429 [PMID:11784146] |
ChEMBL | Displacement of [125I]I-AB-MECA from human adenosine A3 receptor expressed in CHO cells | B | 6.24 | pKi | 570 | nM | Ki | ACS Med Chem Lett (2014) 5: 1043-1048 [PMID:25221664] |
ChEMBL | Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide from human A3 adenosine receptor expressed in CHO cell membranes after 60 mins | B | 6.24 | pKi | 570 | nM | Ki | J Med Chem (2012) 55: 538-552 [PMID:22104008] |
ChEMBL | Displacement of [3H]AB-MECA from human adenosine A3 receptor expressed in CHO cell membranes incubated for 30 mins by scintillation counting method | B | 6.42 | pKi | 384 | nM | Ki | J Med Chem (2015) 58: 3253-3267 [PMID:25780876] |
ChEMBL | Displacement of [125I]I-AB-MECA from human recombinant adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counting analysis | B | 6.94 | pKi | 114 | nM | Ki | Bioorg Med Chem (2013) 21: 436-447 [PMID:23245803] |
ChEMBL | Displacement of [125I]-AB-MECA from human recombinant adenosine A3 receptor | B | 6.94 | pKi | 114 | nM | Ki | ACS Med Chem Lett (2011) 2: 890-895 [PMID:24900277] |
ChEMBL | Inhibition of [3H]NECA binding to human adenosine A3 receptor expressed in HeLa cells | B | 7.17 | pKi | 68 | nM | Ki | J Med Chem (2004) 47: 4041-4053 [PMID:15267242] |
ChEMBL | Displacement of [125I]AB-MECA from membranes of HEK 293 cells expressing human Adenosine A3 receptor | B | 7.17 | pKi | 67.1 | nM | Ki | J Med Chem (1999) 42: 1384-1392 [PMID:10212124] |
ChEMBL | Binding affinity to human recombinant adenosine A3 receptor | B | 7.17 | pKi | 67 | nM | Ki | J Med Chem (2014) 57: 3623-3650 [PMID:24164628] |
ChEMBL | Displacement of [125I]I-AB-MECA from recombinant human adenosine A3 receptor expressed in CHO cells after 60 mins by gamma counting analysis | B | 7.17 | pKi | 67 | nM | Ki | J Med Chem (2016) 59: 788-809 [PMID:26356532] |
GtoPdb | - | - | 7.2 | pKi | - | - | - |
Biochem Pharmacol (2004) 68: 1985-93 [PMID:15476669]; Naunyn Schmiedebergs Arch Pharmacol (1998) 357: 1-9 [PMID:9459566]; Mol Pharmacol (2000) 57: 968-75 [PMID:10779381]; J Med Chem (2004) 47: 4041-53 [PMID:15267242]; Nat Rev Drug Discov (2006) 5: 247-64 [PMID:16518376] |
ChEMBL | Agonist activity at human adenosine A3 receptor expressed in CHO cells by GTPPgammaS binding assay | B | 6.21 | pEC50 | 613 | nM | EC50 | Bioorg Med Chem Lett (2010) 20: 1219-1224 [PMID:20031406] |
ChEMBL | Agonist activity at human adenosine A3 receptor expressed in FlpIn-CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins by fluorescence assay | F | 8 | pEC50 | 10 | nM | EC50 | Medchemcomm (2014) 5: 192-196 |
A3 receptor/Adenosine A3 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3360] [GtoPdb: 21] [UniProtKB: P28647] | ||||||||
GtoPdb | - | - | 6.23 | pKi | 584 | nM | Ki | . A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics (2010) |
ChEMBL | Tested for the binding affinity of A3 receptor by displacing N6-[[125I]-4-amino-3-iodobenzyl]-adenosine-5''-N-methyluronamide from membranes of CHO cells transfected with rat A3-cDNA | B | 6.23 | pKi | 584 | nM | Ki | J Med Chem (1994) 37: 3614-3621 [PMID:7932588] |
ChEMBL | Binding affinity for rat adenosine A3 receptor | B | 6.23 | pKi | 584 | nM | Ki | J Med Chem (1999) 42: 1384-1392 [PMID:10212124] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]